4//SEC Filing
Clark Eliana 4
Accession 0001193125-26-006278
CIK 0001652130other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:03 PM ET
Size
5.0 KB
Accession
0001193125-26-006278
Insider Transaction Report
Form 4
Clark Eliana
EVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2026-01-05$9.21/sh−9,515$87,633→ 87,118 total
Footnotes (2)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
- [F2]Includes 1,264 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2025.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001914448
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:03 PM ET
- Size
- 5.0 KB